Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > FORMAL TAKEOVER BID.
View:
Post by alleyesonme on Dec 14, 2024 6:41pm

FORMAL TAKEOVER BID.

Appears imminent!...medipharm labs has disclosed they have multiple pharma partnerships involved in "NDA's, ANDA, and 505b2 applications with the FDA. This has been on the investor deck for a long time...absolutely proper disclosure has been met....I would image the buyer is one of these partners and hopefully the buyout price is in line with a pharmaceutical Corp valuation.
Comment by alleyesonme on Dec 15, 2024 11:49am
   What's the current fair value of the stock ? .14c?...now what premium will be applied ? 100%?.....28c a share ? Fair...details about partnerships does not constitute a material change in the Corp....10 signs a Corp may be bought out soon https://tekinvestor.s3.dualstack.eu-west-1.amazonaws.com/original/3X/d/e/defca2bfb965feeeb0a7cbc0eb69962948d01bed.pdf
Comment by Solid1 on Dec 15, 2024 1:57pm
If agreements that could significantly change the value of the share are withheld from the shareholder, this is considered deception. The disclosure obligation applies to the prevention of market manipulation and insider trading.... Regarding the nonsense you just claimed... The details are the most important thing, only then can you really measure the value of the company 
Comment by Solid1 on Dec 15, 2024 2:07pm
I don't think Labs will be acquired, but there will be a large and significant partnership, and this pharmaceutical company will acquire a large portion of Medipharm Labs' shares, leaving only a small portion of the shares on the market, which will lead to an increase in the share price. 
Comment by alleyesonme on Dec 15, 2024 3:11pm
If true, the shares wouldn't be acquired on the open market, it would be a private placement adding to the share count. What do you make of the acceleration of RSU's by 13 days? I see this as concern they could be paused during the formal aqusition process..potentially being scrapped altogether once the new owner takes over...parties often have dialogue months even years before terms of a ...more  
Comment by QContinuum1 on Dec 15, 2024 3:47pm
The lunacy has reached a fever pitch.  There is no reason to read anything into 'accelerated' RSUs anymore than the other blather about NDA/ANDA/etc. I've told you before, ANDA is Epi, NDA isn't an NDA, it is an investigational NDA and the whole idea of selling the company on the basis of cloak and daggar secrecy makes no sense. You want to believe something big is imminent. ...more  
Comment by alleyesonme on Dec 15, 2024 4:36pm
Investor deck, we can all read. Let's gather the board, amend the RSU plan to accelerate by 13 days..Just for fun, no reason other than 13 more days is just too far away..yeah makes perfect sense.  Nothing to see here folks. 
Comment by Solid1 on Dec 15, 2024 5:55pm
Of course something will come... the only reason CBD was quiet for years was because of NCE exclusivity, which made it impossible to approve new therapies or new CBD-based drugs. It is no coincidence that all applications for approval coincide exactly with the expiry of this exclusivity. And as for Pidduck, there is nothing strange in his resume so why this accusation? 
Comment by Solid1 on Dec 16, 2024 4:51am
In the last 10 years, 400 INDs in the field of cannabis and CBD have been submitted to the FDA! If I remember correctly, GW Pharma received IND status in 2013 and was approved in 2018, but the road back then was much rockier than it is today. The market has huge potential and there are very few manufacturers so far. Medipharm Labs has already stated that they are working with various ...more  
Comment by QContinuum1 on Dec 16, 2024 7:04am
Reading and understanding are two different things, we've touched on that before as well. And are you suggesting that a material event, by end of month, is imminent?  Anything is possible I suppose, but given we're not on the inside, there are many reasons why things happen, this is more than likely simply one of those times. If you want to hype yourself up, by all means, I'd ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities